{
    "info": {
        "nct_id": "NCT05586360",
        "official_title": "T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer",
        "inclusion_criteria": "1. Men with pathologically-confirmed localized prostate cancer determined to be intermediate (stage T2b, or Gleason 7, or PSA 10-20 ng/mL) or high risk (stage T2c, or PSA >/=20 ng/mL, or Gleason >/=8) of biochemical recurrence at the time of biopsy\n2. Electing to undergo prostatectomy;\n3. Ability to provide written informed consent and willing to complete study procedures.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Current statin use or use of non-statin lipid-lowering drug (fibrates, bile acid sequestrants, or niacin);\n2. Current use of medications contraindicated for concomitant use with 40mg simvastatin:\n\n   * Gemfibrozil\n   * Cyclosporine\n   * Danazol\n   * CYP3A4 inhibitors: itraconazole; ketoconazole; posaconazole; erythromycin; clarithromycin; telithromycin; HIV protease inhibitors; boceprevir; telaprevir; nefazodone\n3. Current use of medications requiring lower dose of simvastatin not already listed as exclusions criteria:\n\n   * Verapamil\n   * Diltiazem\n   * Amiodarone\n   * Ranolazine\n   * Calcium channel blockers: verapamil; diltiazem; amlodipine\n4. Men with low-density lipoprotein cholesterol <50mg/dL\n5. Statin use in the previous 12 months;\n6. Discontinued statin use because of statin-related adverse event;\n7. Evidence or suspicion of metastases;\n8. Prior neoadjuvant or adjuvant chemotherapy, hormone therapy, or radiation therapy;\n9. History of non-prostate cancer other than non-melanoma skin cancer in the last 24 months;\n10. Diagnosed diabetes or currently taking diabetes medications\n11. Prior myocardial infarction or stroke\n12. Chronic liver disease (hepatitis or cirrhosis) or abnormal liver function (>1.5x clinical laboratory's upper limit of normal alanine aminotransferase);\n13. Stage 4 or 5 chronic kidney disease (Creatinine clearance / estimated glomerular filtration rate < 30 mL/min calculated by Cockgroft-Gault formula);\n14. History of myopathy or inflammatory muscle disease (>3x clinical laboratory's upper limit of normal creatine kinase).",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "1. Men with pathologically-confirmed localized prostate cancer determined to be intermediate (stage T2b, or Gleason 7, or PSA 10-20 ng/mL) or high risk (stage T2c, or PSA >/=20 ng/mL, or Gleason >/=8) of biochemical recurrence at the time of biopsy",
            "criterions": [
                {
                    "exact_snippets": "Men",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                },
                {
                    "exact_snippets": "pathologically-confirmed localized prostate cancer",
                    "criterion": "prostate cancer diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "pathological"
                        },
                        {
                            "requirement_type": "localization",
                            "expected_value": "localized"
                        }
                    ]
                },
                {
                    "exact_snippets": "intermediate (stage T2b, or Gleason 7, or PSA 10-20 ng/mL)",
                    "criterion": "risk of biochemical recurrence (intermediate)",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "T2b"
                        },
                        {
                            "requirement_type": "Gleason score",
                            "expected_value": {
                                "operator": "=",
                                "value": 7,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "PSA",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 10,
                                        "unit": "ng/mL"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 20,
                                        "unit": "ng/mL"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "high risk (stage T2c, or PSA >/=20 ng/mL, or Gleason >/=8)",
                    "criterion": "risk of biochemical recurrence (high)",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "T2c"
                        },
                        {
                            "requirement_type": "PSA",
                            "expected_value": {
                                "operator": ">=",
                                "value": 20,
                                "unit": "ng/mL"
                            }
                        },
                        {
                            "requirement_type": "Gleason score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "at the time of biopsy",
                    "criterion": "timing of risk assessment",
                    "requirements": [
                        {
                            "requirement_type": "timepoint",
                            "expected_value": "at the time of biopsy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Electing to undergo prostatectomy;",
            "criterions": [
                {
                    "exact_snippets": "Electing to undergo prostatectomy",
                    "criterion": "prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "electing to undergo",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Ability to provide written informed consent and willing to complete study procedures.",
            "criterions": [
                {
                    "exact_snippets": "Ability to provide written informed consent",
                    "criterion": "written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to complete study procedures",
                    "criterion": "completion of study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "10. Diagnosed diabetes or currently taking diabetes medications",
            "criterions": [
                {
                    "exact_snippets": "Diagnosed diabetes",
                    "criterion": "diabetes",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "currently taking diabetes medications",
                    "criterion": "diabetes medication use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ranolazine",
            "criterions": [
                {
                    "exact_snippets": "* Ranolazine",
                    "criterion": "ranolazine",
                    "requirements": [
                        {
                            "requirement_type": "exposure or use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Evidence or suspicion of metastases;",
            "criterions": [
                {
                    "exact_snippets": "Evidence or suspicion of metastases",
                    "criterion": "metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence or suspicion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Statin use in the previous 12 months;",
            "criterions": [
                {
                    "exact_snippets": "Statin use in the previous 12 months",
                    "criterion": "statin use",
                    "requirements": [
                        {
                            "requirement_type": "use in previous period",
                            "expected_value": {
                                "operator": "=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Gemfibrozil",
            "criterions": [
                {
                    "exact_snippets": "Gemfibrozil",
                    "criterion": "Gemfibrozil use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Prior myocardial infarction or stroke",
            "criterions": [
                {
                    "exact_snippets": "Prior myocardial infarction",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior ... stroke",
                    "criterion": "stroke",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Danazol",
            "criterions": [
                {
                    "exact_snippets": "Danazol",
                    "criterion": "Danazol use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Discontinued statin use because of statin-related adverse event;",
            "criterions": [
                {
                    "exact_snippets": "Discontinued statin use",
                    "criterion": "statin use",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "because of statin-related adverse event",
                    "criterion": "statin-related adverse event",
                    "requirements": [
                        {
                            "requirement_type": "cause of statin discontinuation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Men with low-density lipoprotein cholesterol <50mg/dL",
            "criterions": [
                {
                    "exact_snippets": "Men",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                },
                {
                    "exact_snippets": "low-density lipoprotein cholesterol <50mg/dL",
                    "criterion": "low-density lipoprotein cholesterol",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Current use of medications requiring lower dose of simvastatin not already listed as exclusions criteria:",
            "criterions": [
                {
                    "exact_snippets": "Current use of medications requiring lower dose of simvastatin",
                    "criterion": "concomitant medication use",
                    "requirements": [
                        {
                            "requirement_type": "medication interaction with simvastatin",
                            "expected_value": "requires lower dose of simvastatin"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Verapamil",
            "criterions": [
                {
                    "exact_snippets": "Verapamil",
                    "criterion": "verapamil use",
                    "requirements": [
                        {
                            "requirement_type": "use or exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* CYP3A4 inhibitors: itraconazole; ketoconazole; posaconazole; erythromycin; clarithromycin; telithromycin; HIV protease inhibitors; boceprevir; telaprevir; nefazodone",
            "criterions": [
                {
                    "exact_snippets": "CYP3A4 inhibitors: itraconazole; ketoconazole; posaconazole; erythromycin; clarithromycin; telithromycin; HIV protease inhibitors; boceprevir; telaprevir; nefazodone",
                    "criterion": "CYP3A4 inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "use of specific drugs",
                            "expected_value": [
                                "itraconazole",
                                "ketoconazole",
                                "posaconazole",
                                "erythromycin",
                                "clarithromycin",
                                "telithromycin",
                                "HIV protease inhibitors",
                                "boceprevir",
                                "telaprevir",
                                "nefazodone"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Calcium channel blockers: verapamil; diltiazem; amlodipine",
            "criterions": [
                {
                    "exact_snippets": "Calcium channel blockers: verapamil; diltiazem; amlodipine",
                    "criterion": "calcium channel blocker use",
                    "requirements": [
                        {
                            "requirement_type": "use of specific medications",
                            "expected_value": [
                                "verapamil",
                                "diltiazem",
                                "amlodipine"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Chronic liver disease (hepatitis or cirrhosis) or abnormal liver function (>1.5x clinical laboratory's upper limit of normal alanine aminotransferase);",
            "criterions": [
                {
                    "exact_snippets": "Chronic liver disease (hepatitis or cirrhosis)",
                    "criterion": "chronic liver disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "abnormal liver function (>1.5x clinical laboratory's upper limit of normal alanine aminotransferase)",
                    "criterion": "liver function (alanine aminotransferase)",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "x upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Current use of medications contraindicated for concomitant use with 40mg simvastatin:",
            "criterions": [
                {
                    "exact_snippets": "Current use of medications contraindicated for concomitant use with 40mg simvastatin",
                    "criterion": "use of contraindicated medications with simvastatin",
                    "requirements": [
                        {
                            "requirement_type": "concomitant use with 40mg simvastatin",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraindication",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Amiodarone",
            "criterions": [
                {
                    "exact_snippets": "Amiodarone",
                    "criterion": "amiodarone use",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cyclosporine",
            "criterions": [
                {
                    "exact_snippets": "Cyclosporine",
                    "criterion": "cyclosporine use",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diltiazem",
            "criterions": [
                {
                    "exact_snippets": "Diltiazem",
                    "criterion": "diltiazem use",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. History of myopathy or inflammatory muscle disease (>3x clinical laboratory's upper limit of normal creatine kinase).",
            "criterions": [
                {
                    "exact_snippets": "History of myopathy",
                    "criterion": "myopathy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "inflammatory muscle disease",
                    "criterion": "inflammatory muscle disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": ">3x clinical laboratory's upper limit of normal creatine kinase",
                    "criterion": "creatine kinase level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. History of non-prostate cancer other than non-melanoma skin cancer in the last 24 months;",
            "criterions": [
                {
                    "exact_snippets": "History of non-prostate cancer other than non-melanoma skin cancer in the last 24 months",
                    "criterion": "history of non-prostate cancer (excluding non-melanoma skin cancer)",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Prior neoadjuvant or adjuvant chemotherapy, hormone therapy, or radiation therapy;",
            "criterions": [
                {
                    "exact_snippets": "Prior neoadjuvant or adjuvant chemotherapy",
                    "criterion": "prior neoadjuvant or adjuvant chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hormone therapy",
                    "criterion": "prior hormone therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "radiation therapy",
                    "criterion": "prior radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. Stage 4 or 5 chronic kidney disease (Creatinine clearance / estimated glomerular filtration rate < 30 mL/min calculated by Cockgroft-Gault formula);",
            "criterions": [
                {
                    "exact_snippets": "Stage 4 or 5 chronic kidney disease",
                    "criterion": "chronic kidney disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "4",
                                "5"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Creatinine clearance / estimated glomerular filtration rate < 30 mL/min calculated by Cockgroft-Gault formula",
                    "criterion": "creatinine clearance or estimated glomerular filtration rate",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "mL/min"
                            }
                        },
                        {
                            "requirement_type": "calculation method",
                            "expected_value": "Cockgroft-Gault formula"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Current statin use or use of non-statin lipid-lowering drug (fibrates, bile acid sequestrants, or niacin);",
            "criterions": [
                {
                    "exact_snippets": "Current statin use",
                    "criterion": "statin use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "use of non-statin lipid-lowering drug (fibrates, bile acid sequestrants, or niacin)",
                    "criterion": "non-statin lipid-lowering drug use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "drug classes",
                            "expected_value": [
                                "fibrates",
                                "bile acid sequestrants",
                                "niacin"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}